Drugs / Elsulfavirine
Elsulfavirine
also known as
Elpida · VM-1500 · Elsulfavirina · ELSULFAVIRINE SODIUM · R-1206 · R-1206 SODIUM · R1206(SODIUM SALT) · VM-1500A-LAI
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 18 trials | ||||||
| Phase 1 | NCT05165550 | Apr → Jul 2022 | HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 1 | NCT05148754 | Jan → Aug 2021 | COVID-19, HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 1 | NCT03730311 | May → Nov 2019 | HIV infectious disease | Viriom | Unknown | No outcome recorded |
| Phase 1 | NCT05204121 | Dec 2018 → Apr 2019 | HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 1 | NCT03709355 | Nov 2018 → Sep 2019 | HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 1 | NCT03706898 | Oct 2018 → Apr 2019 | HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 1 | NCT02489487 | Sep → Oct 2014 | HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 1 | NCT02489435 | Jul 2012 → Jun 2013 | HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02485509 | Mar → Dec 2013 | HIV infectious disease | Viriom | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT05204394 | Apr 2022 → Sep 2023 | HIV infectious disease | Viriom | Unknown | No outcome recorded |
| Phase 2/3 | NCT02489461 | Aug 2014 → Apr 2016 | HIV infectious disease | Viriom | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03706924 Comparator | Jun → Oct 2018 | HIV infectious disease | Viriom | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Elsulfavirine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05148754 ↗ |
| Known as | Elpida | “Elsulfavirine (Elpida®) 20 mg capsules for oral administration” NCT05165550 ↗ |
| Known as | Elsulfavirina | ChEMBL registry synonym — accepted as the source's own label CHEMBL4301163 ↗ |
| Known as | ELSULFAVIRINE SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4301163 ↗ |
| Known as | R-1206 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4301163 ↗ |
| Known as | R-1206 SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4301163 ↗ |
| Known as | R1206(SODIUM SALT) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4301163 ↗ |
| Known as | VM-1500 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02489487 ↗ |
| Known as | VM-1500A-LAI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05204394 ↗ |
| Modality | Small molecule | — CHEMBL4301163 ↗ |
| Route | Oral | “multiple oral administration” NCT02489435 ↗ |